OLY1 Stock Overview
Olympus Corporation manufactures and sells precision machineries and instruments worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Olympus Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥13.00 |
| 52 Week High | JP¥16.60 |
| 52 Week Low | JP¥11.14 |
| Beta | 0.57 |
| 1 Month Change | -0.038% |
| 3 Month Change | -3.42% |
| 1 Year Change | -16.27% |
| 3 Year Change | -24.16% |
| 5 Year Change | 33.83% |
| Change since IPO | 165.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| OLY1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.4% | 2.1% | 0.5% |
| 1Y | -16.3% | -8.4% | 1.3% |
Return vs Industry: OLY1 underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: OLY1 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| OLY1 volatility | |
|---|---|
| OLY1 Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: OLY1 has not had significant price volatility in the past 3 months.
Volatility Over Time: OLY1's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 32,844 | Stefan Kaufmann | www.olympus-global.com |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.
Olympus Corporation Fundamentals Summary
| OLY1 fundamental statistics | |
|---|---|
| Market cap | €15.27b |
| Earnings (TTM) | €236.40m |
| Revenue (TTM) | €5.49b |
64.6x
P/E Ratio2.8x
P/S RatioIs OLY1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OLY1 income statement (TTM) | |
|---|---|
| Revenue | JP¥916.09b |
| Cost of Revenue | JP¥301.53b |
| Gross Profit | JP¥614.56b |
| Other Expenses | JP¥575.09b |
| Earnings | JP¥39.47b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 33.86 |
| Gross Margin | 67.08% |
| Net Profit Margin | 4.31% |
| Debt/Equity Ratio | 40.6% |
How did OLY1 perform over the long term?
See historical performance and comparison